Laura Bartels-Peculis currently serves as the Medical Director of Health Economics and Outcomes Research (HEOR) at AbbVie, where she leverages her extensive background in medical affairs and economic modeling to drive strategic initiatives that enhance patient outcomes and inform healthcare decision-making. With a Pharm.D. and...
Laura Bartels-Peculis currently serves as the Medical Director of Health Economics and Outcomes Research (HEOR) at AbbVie, where she leverages her extensive background in medical affairs and economic modeling to drive strategic initiatives that enhance patient outcomes and inform healthcare decision-making. With a Pharm.D. and a wealth of experience as a Senior Medical Science Liaison, Laura is adept at bridging the gap between clinical research and real-world application, ensuring that the value of AbbVie’s therapies is clearly communicated to stakeholders.
In her role, Laura leads key projects focused on generating robust HEOR data that supports the clinical and economic value of AbbVie’s portfolio, particularly in therapeutic areas such as diabetes, cardiology, immunology, endocrinology, and neurology. Her expertise in patient-reported outcomes and familiarity with frameworks like the Institute for Clinical and Economic Review (ICER) enable her to design and implement research that resonates with both clinicians and payers. Laura is also instrumental in developing FDAMA 114 presentation materials, ensuring compliance while effectively conveying the benefits of innovative treatments.
Her commitment to advancing healthcare outcomes is reflected in her proficiency in both prospective and retrospective data analysis, allowing her to derive insights that inform clinical practice and policy. By fostering collaborations across multidisciplinary teams, Laura plays a pivotal role in shaping the future of healthcare delivery, ultimately striving to improve patient access to high-quality therapies. Her leadership in HEOR not only enhances AbbVie’s strategic positioning but also contributes to the broader goal of optimizing health outcomes in diverse patient populations.
